PPARγ and RXR form a complex with βRARE in the RARβ promoter, and the combination of ligands of PPARγ and RXR was reported to induce RARβ in ATRA-resistant breast cancer cells in the presence of histone deacetylase inhibitor [94]. This evidence concerns the gene PPARG and breast carcinoma.